01 / The question
What if the protective peptide is the toxic one?
The initial question concerned the cytotoxicity of amyloid material and a possible protective effect of the peptide LK11. The experiments described in the notes used C2C12 mouse myoblasts and soluble or aggregated insulin.
02 / The intuition
A mechanism worth testing.
Test the components separately before interpreting their combination. A change in cell survival can otherwise be attributed to the wrong molecule.
03 / The work
Inside the method.
Explore each part of the approach.
01Separate the conditions
The study compared controls, insulin preparations, LK11 and combinations, with replicate wells.
02Read cell viability
Hoechst and propidium iodide imaging, followed by ImageJ counting, provided a way to compare total and membrane-compromised cells.
03Follow the unexpected result
Dose-response experiments, fluorescent peptide localisation and changes in the combination conditions explored the toxicity seen with LK11 itself.
Mortality (%) = 100 × PI-positive cells / total counted cells
The readout depends on staining, image acquisition and how cells are counted. It does not identify a molecular mechanism.
04 / The observations
What emerged.
The notes report LK11 cytotoxicity under the tested conditions and lower toxicity in some insulin-combination conditions. They propose a peptide–insulin interaction as a new hypothesis; they do not establish the mechanism.
This account is based on recorded project notes. Original reports, figures and datasets are not embedded here.
05 / The limits
Where the evidence stops.
This was a cell-culture study with insulin-derived material, not evidence of an Alzheimer’s treatment. Images, replicate-level measurements and uncertainty estimates are still needed for quantitative interpretation.
The academic foundations